Promises and challenges of adoptive T-cell therapies for solid tumours
Journal article
Morotti M. et al, (2021), British Journal of Cancer, 124, 1759 - 1776
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer.
Journal article
Alexander PG. et al, (2020), Br J Cancer
Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer.
Journal article
Bergsland CH. et al, (2020), ESMO open, 5
PROGNOSTIC INTEGRATED IMAGE-BASED IMMUNE AND MOLECULAR PROFILING IN EARLY-STAGE ENDOMETRIAL CANCER.
Journal article
Horeweg N. et al, (2020), Cancer immunology research
The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability.
Journal article
Russell H. et al, (2020), Clinical epigenetics, 12
Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer.
Journal article
Roseweir AK. et al, (2020), The journal of pathology. Clinical research
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
Journal article
León-Castillo A. et al, (2020), The Journal of pathology, 250, 312 - 322
Interpretation of somatic POLE mutations in endometrial carcinoma.
Journal article
León-Castillo A. et al, (2020), The Journal of pathology, 250, 323 - 335
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study.
Journal article
Skrede O-J. et al, (2020), Lancet (London, England), 395, 350 - 360
Correction: Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage.
Journal article
Glaire MA. et al, (2019), British journal of cancer, 121
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome.
Journal article
Crosbie EJ. et al, (2019), Genetics in medicine : official journal of the American College of Medical Genetics, 21, 2390 - 2400
ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study
Conference paper
Lee LYW. et al, (2019), Cancer Medicine
Hand-foot syndrome is a biomarker of improved survival following treatment with capecitabine.
Conference paper
Jandu H. et al, (2019), Annals of oncology : official journal of the European Society for Medical Oncology, 30 Suppl 4, iv117 - iv118
POLEM: Avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III dMMR or POLE exonuclease domain mutant colon cancer A phase III randomized study.
Conference paper
Lau D. et al, (2019), JOURNAL OF CLINICAL ONCOLOGY, 37
A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer.
Journal article
Workel HH. et al, (2019), Cancer Immunol Res, 7, 784 - 796
Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.
Journal article
de Jonge MM. et al, (2019), Clin Cancer Res, 25, 1087 - 1097
Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer.
Journal article
Gray V. et al, (2019), J Natl Cancer Inst
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.
Journal article
Domingo E. et al, (2018), Lancet Gastroenterol Hepatol, 3, 635 - 643
Adjuvant Treatment for POLE Proofreading Domain-Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues.
Journal article
Van Gool IC. et al, (2018), Clin Cancer Res, 24, 3197 - 3203